+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Preliminary Experience with Low-dose Desmopressin Treatment and Urinary Arginine Vasopressin Concentration as a Response Predictor for Patients with Nocturia with Nocturnal Polyuria



Preliminary Experience with Low-dose Desmopressin Treatment and Urinary Arginine Vasopressin Concentration as a Response Predictor for Patients with Nocturia with Nocturnal Polyuria



Lower Urinary Tract Symptoms 6(2): 107-112



To assess whether urinary arginine vasopressin (AVP) concentrations adjusted for urinary creatinine (Cr) can predict responsiveness to low-dose desmopressin for nocturia with nocturnal polyuria (NP). Nine NP patients aged 64-84 years with ≥ 2 nocturnal voids received 2.5 µg of intranasal desmopressin for 4 weeks and were evaluated for its effectiveness. Prior to treatment, urinary AVP/Cr concentrations at first morning void and serum sodium and plasma natriuretic peptide (BNP) concentrations were measured, and all patients underwent 5% hypertonic saline infusion. Six responders to 2.5 µg desmopressin had average decreases in nocturnal frequency from 3.2 to 1.8 voids nightly and in nocturnal diuresis by 40%, without clinically significant adverse events. Non-responders remained unaffected even with dose escalation to 5.0 µg desmopressin. For responders, urinary AVP/Cr concentrations were less than 14 pg/mg · Cr, which is lower than in non-responders. Within a physiological range of plasma osmolality, plasma AVP release in response to 5% hypertonic saline infusion was less in responders than in non-responders. Blood pressure measurements and BNP concentrations were unchanged. Urinary AVP/Cr at first morning void may have potential clinical value as a predictor for responsiveness to low-dose desmopressin in nocturia with NP.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058603412

Download citation: RISBibTeXText

PMID: 26663550

DOI: 10.1111/luts.12028


Related references

Comparison of nocturia response to desmopressin treatment in elderly men with and without nocturnal polyuria in real-life practice. International Journal of Clinical Practice 70(5): 372-379, 2017

Low-dose Desmopressin Orally Disintegrating Tablet: Suggested Clinically Meaningful Benefit in Patients with Nocturia Due to Nocturnal Polyuria. European Urology Focus 2018, 2018

A clinical investigation of nocturnal polyuria in patients with nocturia: a diurnal variation in arginine vasopressin secretion and its relevance to mean blood pressure. Journal of Urology 176(2): 660-664, 2006

Low-dose oral desmopressin for treatment of nocturia and nocturnal enuresis in patients after radical cystectomy and orthotopic urinary diversion. Bju International 114(5): 727-732, 2015

Desmopressin is an effective treatment for mixed nocturia with nocturnal polyuria and decreased nocturnal bladder capacity. Journal of Korean Medical Science 25(12): 1792-1797, 2011

Decrease in nocturnal urinary levels of arginine vasopressin in patients with nocturnal polyuria. Urology 68(1): 19-23, 2006

Efficacy of intranasal desmopressin in the treatment of nocturia due to nocturnal polyuria. Hinyokika Kiyo. Acta Urologica Japonica 51(3): 151-154, 2005

Nocturia due to nocturnal polyuria (Np) in women with overactive bladder (Oab) may be better managed by adding a low-dose desmopressin to tolterodine therapy. European Urology Suppl.s 15(3): e537-e537a, 2016

Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). World Journal of Urology 32(5): 1163-1170, 2015

Cutoff value of urinary arginine vasopressin for nocturnal polyuria in elderly men. Urology 69(1): 98-102, 2007

Maximal bladder capacity is a positive predictor of response to desmopressin treatment in patients with MS and nocturia. International Urology and Nephrology 40(1): 65-69, 2007

Comparison of nocturia response to desmopressin treatment between patients with normal and high nocturnal bladder capacity index. Thescientificworldjournal 2013: 878564, 2014

Desmopressin for the treatment of nocturnal polyuria in the elderly: A dose titration study. BJU 82(5): 642-646, 1998

Nocturnal polyuria and natriuresis in male patients with nocturia and lower urinary tract symptoms. Journal Of Urology. 156(4): 1292-1299, 1996

Nocturia in men with lower urinary tract symptoms is associated with both nocturnal polyuria and detrusor overactivity with positive response to ice water test. Urology 65(6): 1064-1069, 2005